NCT00562250 - Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Dapagliflozin

Tablets, Oral, 20 mg, once daily, single dose

DRUG

Glimepiride

Tablets, Oral, 4 mg, once daily, single dose

DRUG

Dapagliflozin + Glimepiride

Tablets, Oral, Dapagliflozin 20 mg + Glimepiride 4 mg, once daily, single dose

Trial Locations (1)

Local Institution, Vicente López